Td Asset Management Inc Summit Therapeutics Inc. Transaction History
Td Asset Management Inc
- $108 Billion
- Q2 2025
A detailed history of Td Asset Management Inc transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 484,010 shares of SMMT stock, worth $13.9 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
484,010
Previous 807,190
40.04%
Holding current value
$13.9 Million
Previous $15.6 Million
33.85%
% of portfolio
0.01%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding SMMT
# of Institutions
246Shares Held
87.3MCall Options Held
1.77MPut Options Held
2.49M-
Baker Bros. Advisors LP New York, NY24.4MShares$700 Million5.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.6MShares$334 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$226 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.56MShares$188 Million0.02% of portfolio
-
State Street Corp Boston, MA4.85MShares$139 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $5.77B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...